newsfilter
← Latest News
ACCESS Newswire·

Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Strategic focus on exploratory investigator-initiated clinical studies with institutional partnersContinued progress of DNase I development program towards IND and first-in-human study for treatment of pancreatic